Evidence map›Paper›PMID 34480604›Full record

ArticleArchives of toxicology2021

Fluorescent tagging of endogenous Heme oxygenase-1 in human induced pluripotent stem cells for high content imaging of oxidative stress in various differentiated lineages.

Kirsten E Snijders, Anita Fehér, Zsuzsanna Táncos, István Bock, Annamária Téglási, Linda van den Berk, Marije Niemeijer, Peter Bouwman, Sylvia E Le Dévédec, Martijn J Moné and 9 more

Open access · hybridAbstract read
In one paragraph

Article in Archives of toxicology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 4 institutions in 3 countries.

Kirsten E Snijders *Division of Drug Discovery and Safety, Leiden Academic Centre for Drug Research, Leiden University, Einsteinweg 55, 2333 CC, Leiden, The Netherlands.ORCID 0000-0002-9683-6528
Anita Fehér *BioTalentum Ltd., 2100, Gödöllő, Hungary.ORCID 0000-0002-7832-0886
Zsuzsanna TáncosBioTalentum Ltd., 2100, Gödöllő, Hungary.ORCID 0000-0003-1972-5215
István BockBioTalentum Ltd., 2100, Gödöllő, Hungary.ORCID 0000-0001-9178-4506
Annamária TéglásiBioTalentum Ltd., 2100, Gödöllő, Hungary.
Linda van den BerkDivision of Drug Discovery and Safety, Leiden Academic Centre for Drug Research, Leiden University, Einsteinweg 55, 2333 CC, Leiden, The Netherlands.ORCID 0000-0001-7887-2050
Marije NiemeijerDivision of Drug Discovery and Safety, Leiden Academic Centre for Drug Research, Leiden University, Einsteinweg 55, 2333 CC, Leiden, The Netherlands.ORCID 0000-0003-0045-2317
Peter BouwmanDivision of Drug Discovery and Safety, Leiden Academic Centre for Drug Research, Leiden University, Einsteinweg 55, 2333 CC, Leiden, The Netherlands.ORCID 0000-0002-9252-5896
Sylvia E Le DévédecDivision of Drug Discovery and Safety, Leiden Academic Centre for Drug Research, Leiden University, Einsteinweg 55, 2333 CC, Leiden, The Netherlands.ORCID 0000-0002-0615-9616
Martijn J MonéDivision of Drug Discovery and Safety, Leiden Academic Centre for Drug Research, Leiden University, Einsteinweg 55, 2333 CC, Leiden, The Netherlands.
Rob Van RossomDepartment of Development and Regeneration, Stem Cell Institute, KU Leuven, Leuven, Belgium.
Manoj KumarDepartment of Development and Regeneration, Stem Cell Institute, KU Leuven, Leuven, Belgium.ORCID 0000-0002-0572-5786
Anja WilmesDivision of Molecular and Computational Toxicology, Amsterdam Institute for Molecules, Medicines and Systems, Amsterdam, The Netherlands.ORCID 0000-0001-9485-4565
Paul JenningsDivision of Molecular and Computational Toxicology, Amsterdam Institute for Molecules, Medicines and Systems, Amsterdam, The Netherlands.ORCID 0000-0002-6860-2898
Catherine M VerfaillieDepartment of Development and Regeneration, Stem Cell Institute, KU Leuven, Leuven, Belgium.ORCID 0000-0001-7564-4079
Julianna KobolákBioTalentum Ltd., 2100, Gödöllő, Hungary.ORCID 0000-0002-0986-9517
Bas Ter BraakDivision of Drug Discovery and Safety, Leiden Academic Centre for Drug Research, Leiden University, Einsteinweg 55, 2333 CC, Leiden, The Netherlands.ORCID 0000-0002-7290-4119
András DinnyésBioTalentum Ltd., 2100, Gödöllő, Hungary. andras.dinnyes@biotalentum.hu.ORCID 0000-0003-3791-2583
Bob van de WaterDivision of Drug Discovery and Safety, Leiden Academic Centre for Drug Research, Leiden University, Einsteinweg 55, 2333 CC, Leiden, The Netherlands. b.water@lacdr.leidenuniv.nl.ORCID 0000-0002-5839-2380
Leiden University · NLBioTalentum (Hungary) · HUKU Leuven · BEMagyar Agrár- és Élettudományi Egyetem · HU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tagging of endogenous stress response genes can provide valuable in vitro models for chemical safety assessment. Here, we present the generation and application of a fluorescent human induced pluripotent stem cell (hiPSC) reporter line for Heme oxygenase-1 (HMOX1), which is considered a sensitive and reliable biomarker for the oxidative stress response. CRISPR/Cas9 technology was used to insert an enhanced green fluorescent protein (eGFP) at the C-terminal end of the endogenous HMOX1 gene. Individual clones were selected and extensively characterized to confirm precise editing and retained stem cell properties. Bardoxolone-methyl (CDDO-Me) induced oxidative stress caused similarly increased expression of both the wild-type and eGFP-tagged HMOX1 at the mRNA and protein level. Fluorescently tagged hiPSC-derived proximal tubule-like, hepatocyte-like, cardiomyocyte-like and neuron-like progenies were treated with CDDO-Me (5.62-1000 nM) or diethyl maleate (5.62-1000 µM) for 24 h and 72 h. Multi-lineage oxidative stress responses were assessed through transcriptomics analysis, and HMOX1-eGFP reporter expression was carefully monitored using live-cell confocal imaging. We found that eGFP intensity increased in a dose-dependent manner with dynamics varying amongst lineages and stressors. Point of departure modelling further captured the specific lineage sensitivities towards oxidative stress. We anticipate that the newly developed HMOX1 hiPSC reporter will become a valuable tool in understanding and quantifying critical target organ cell-specific oxidative stress responses induced by (newly developed) chemical entities.

Indexed as

Cell DifferentiationCells, CulturedCRISPR-Cas SystemsDose-Response Relationship, DrugGreen Fluorescent ProteinsHeme Oxygenase-1HumansInduced Pluripotent Stem CellsMaleMaleatesMiddle AgedOleanolic AcidOxidative StressRNA, MessengerTime Factorsbardoxolone methyldiethyl maleateenhanced green fluorescent proteinGreen Fluorescent ProteinsHeme Oxygenase-1HMOX1 protein, humanMaleatesOleanolic AcidRNA, MessengerEndogenous gene taggingHigh content imagingInduced pluripotent stem cellsIn vitro toxicologyOxidative stressReporter cells

Identifiers

PMID34480604
PMCPMC8448683
OpenAlexW3196767092

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.